[go: up one dir, main page]

WO2025013363A1 - Water treatment apparatus and water treatment method - Google Patents

Water treatment apparatus and water treatment method Download PDF

Info

Publication number
WO2025013363A1
WO2025013363A1 PCT/JP2024/013828 JP2024013828W WO2025013363A1 WO 2025013363 A1 WO2025013363 A1 WO 2025013363A1 JP 2024013828 W JP2024013828 W JP 2024013828W WO 2025013363 A1 WO2025013363 A1 WO 2025013363A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
water treatment
reverse osmosis
membrane
osmosis membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/JP2024/013828
Other languages
French (fr)
Japanese (ja)
Inventor
雄大 鈴木
樹生 木田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organo Corp
Original Assignee
Organo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organo Corp filed Critical Organo Corp
Publication of WO2025013363A1 publication Critical patent/WO2025013363A1/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B01D61/04Feed pretreatment
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/02Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/44Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • C02F5/10Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F5/00Softening water; Preventing scale; Adding scale preventatives or scale removers to water, e.g. adding sequestering agents
    • C02F5/08Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents
    • C02F5/10Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances
    • C02F5/14Treatment of water with complexing chemicals or other solubilising agents for softening, scale prevention or scale removal, e.g. adding sequestering agents using organic substances containing phosphorus

Definitions

  • the present invention relates to a water treatment device and a water treatment method that use a reverse osmosis membrane.
  • the recovery rate of the reverse osmosis membrane treatment equipment is determined so that the concentration of scale components in the concentrated water from the reverse osmosis membrane treatment does not exceed the solubility of each solute, and the Langelier index (LSI) is less than 0.
  • LSI Langelier index
  • LSI Limit Saturation Index
  • LSI is known as an index of the risk of scale including hardness components, and is calculated from the pH, calcium ion concentration, total alkalinity, and soluble substance concentration of the water. The larger this value is, the more likely it is that calcium carbonate will precipitate, and the more likely it is that other scales with similar properties, centered around calcium carbonate, will precipitate or co-precipitate.
  • LSI can be calculated using formula (1) described below.
  • the object of the present invention is to provide a water treatment device and a water treatment method that can suppress the progression of clogging of the reverse osmosis membrane caused by scale during reverse osmosis membrane treatment.
  • the present invention is a water treatment device that includes a reverse osmosis membrane treatment means for passing water to be treated that contains at least one of calcium and aluminum through a reverse osmosis membrane to obtain permeate water and concentrated water, and a scale inhibitor addition means for adding a scale inhibitor to the water to be treated, the reverse osmosis membrane being a neutrally charged membrane.
  • the water to be treated further contains silica.
  • the scale inhibitor preferably contains at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.
  • the neutrally charged membrane is a neutrally charged membrane with a zeta potential on the membrane surface of -10 mV or more and +10 mV or less.
  • the Langelier index of the concentrated water exceeds 0.
  • the silica concentration in the concentrated water is 120 mg/L or more.
  • the aluminum concentration in the concentrated water is 0.25 mg/L or more.
  • the concentrated water has a Langelier index greater than 0, a silica concentration of 120 mg/L or more, and an aluminum concentration of 0.25 mg/L or more.
  • the present invention is a water treatment method that includes a reverse osmosis membrane treatment step in which water to be treated that contains at least one of calcium and aluminum is passed through a reverse osmosis membrane to obtain permeate water and concentrated water, and a scale inhibitor addition step in which a scale inhibitor is added to the water to be treated, the reverse osmosis membrane being a neutrally charged membrane.
  • the water to be treated further contains silica.
  • the scale inhibitor preferably contains at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.
  • the neutrally charged membrane is a neutrally charged membrane whose membrane surface has a zeta potential of -10 mV or more and +10 mV or less.
  • the Langelier index of the concentrated water exceeds 0.
  • the silica concentration in the concentrated water is 120 mg/L or more.
  • the aluminum concentration in the concentrated water is 0.25 mg/L or more.
  • the concentrated water has a Langelier index greater than 0, a silica concentration of 120 mg/L or more, and an aluminum concentration of 0.25 mg/L or more.
  • the present invention provides a water treatment device and a water treatment method that can suppress the progression of blockage of the reverse osmosis membrane caused by scale during reverse osmosis membrane treatment.
  • 1 is a schematic diagram illustrating an example of a water treatment device according to an embodiment of the present invention.
  • 1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 1 and Comparative Example 1.
  • 1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 2 and Comparative Example 2.
  • 1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 3 and Comparative Example 3.
  • 1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 4 and Comparative Example 4.
  • 1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 5 and Comparative Example 5.
  • the water treatment device is a water treatment device that includes a reverse osmosis membrane treatment means for passing water to be treated that contains at least one of calcium and aluminum through a reverse osmosis membrane to obtain permeate water and concentrated water, and a scale inhibitor addition means for adding a scale inhibitor to the water to be treated, and the reverse osmosis membrane is a neutrally charged membrane.
  • FIG. 1 An example of a water treatment device according to an embodiment of the present invention is outlined in FIG. 1, and its configuration will be described.
  • the water treatment device 1 includes a reverse osmosis membrane treatment device 12 as a reverse osmosis membrane treatment means for passing water to be treated, which contains at least one of calcium and aluminum, through a reverse osmosis membrane to obtain permeate water and concentrated water.
  • the reverse osmosis membrane used in the reverse osmosis membrane treatment device 12 is a neutrally charged membrane.
  • the water treatment device 1 may also include a water tank 10 for storing water to be treated, which contains at least one of calcium and aluminum.
  • a treated water pipe 14 is connected to the treated water inlet of the treated water tank 10.
  • the treated water outlet of the treated water tank 10 and the treated water inlet of the reverse osmosis membrane treatment device 12 are connected by a treated water pipe 16.
  • a permeated water pipe 18 is connected to the permeated water outlet of the reverse osmosis membrane treatment device 12, and a concentrated water pipe 20 is connected to the concentrated water outlet.
  • a scale inhibitor addition pipe 22 is connected to the chemical inlet of the treated water tank 10.
  • the water to be treated which contains at least one of calcium and aluminum, is stored in the water to be treated tank 10 as necessary through the water to be treated piping 14.
  • a scale inhibitor is added to the water to be treated through the scale inhibitor addition piping 22 (scale inhibitor addition process).
  • the water to be treated to which the scale inhibitor has been added is sent to the reverse osmosis membrane treatment device 12 through the water to be treated piping 16.
  • the scale inhibitor may be added via a line in the water to be treated piping 14 or the water to be treated piping 16.
  • reverse osmosis membrane treatment is performed in which the water to be treated is passed through a reverse osmosis membrane to obtain permeated water and concentrated water (reverse osmosis membrane treatment process).
  • the permeated water is discharged through the permeated water pipe 18, and the concentrated water is discharged through the concentrated water pipe 20.
  • the inventors have found that when a neutrally charged membrane is used as the reverse osmosis membrane, clogging of the reverse osmosis membrane by scale is less likely to progress compared to when an anion-charged membrane is used. This is thought to be because cations such as calcium and aluminum, which are typical scale components, are attracted to the vicinity of the membrane by charge and concentrated to a high concentration in an anion-charged membrane, whereas this phenomenon is less likely to occur in a neutrally charged membrane.
  • silica is anionic, it is known that precipitation is promoted by cations such as calcium and aluminum. Therefore, it is thought that using a neutrally charged membrane is also effective for the purpose of suppressing silica precipitation.
  • Neutral-charged membranes are mainly used in the wastewater treatment field.
  • the surface of a reverse osmosis membrane is anion-charged, but by neutralizing the charge through surface treatment such as coating, it is possible to suppress membrane surface contamination, mainly caused by organic matter.
  • the surface treatment due to the surface treatment, the amount of permeated water is lower than with an anion-charged membrane, and there is a disadvantage that the operating pressure of the pump and power consumption increase when trying to produce the same amount of water. Therefore, unless there is a special reason, it is common to use an anion-charged membrane. For example, in applications where pure water is produced from groundwater, anion-charged membranes are used together with scale inhibitors.
  • Reverse osmosis membranes include neutrally charged membranes, anionically charged membranes, and cationically charged membranes.
  • a membrane with a zeta potential at pH 7.0 determined by the zeta potential measurement method described in the Examples below in the range of -10 mV to 10 mV is defined as a neutrally charged membrane
  • a membrane with a zeta potential of more than 10 mV is defined as a cationically charged membrane
  • a membrane with a zeta potential of less than -10 mV is defined as an anionically charged membrane.
  • Organic substances that tend to contaminate reverse osmosis membranes are often anionic, and in order to suppress their adhesion, it is preferable that the zeta potential of a neutral membrane is in the range of -10 to 0 mV.
  • neutrally charged membranes include, for example, BW30XFR (Dow Chemical Company), LFC3 (Nitto Denko Corporation), TML20 (Toray Industries, Inc.), and OFR625 (all manufactured by Organo Corporation).
  • ES10C manufactured by Nitto Denko Corporation.
  • anion-charged membranes include, for example, ES15, ES20, CPA3, and CPA5 (all manufactured by Nitto Denko Corporation) and RE-8040BLN (manufactured by Woongjin Co., Ltd.).
  • the water to be treated contains at least one of calcium and aluminum.
  • the water to be treated may further contain silica, magnesium, etc.
  • the water to be treated containing at least one of calcium and aluminum may be water containing at least one of calcium and aluminum, and is not particularly limited, but examples include coagulation treated water, membrane filtration treated water, industrial water, etc.
  • the pH of the water to be treated is, for example, in the range of 4.0 to 10.0, and preferably in the range of 5.5 to 9.0. If the pH of the water to be treated is less than 4.0, the rejection rate of the reverse osmosis membrane may drop sharply and the quality of the permeated water may deteriorate, and if it exceeds 10.0, the reverse osmosis membrane may deteriorate due to hydrolysis.
  • a pH adjuster such as an acid, e.g., hydrochloric acid, sulfuric acid, or nitric acid, or an alkali, e.g., an aqueous solution of sodium hydroxide or an aqueous solution of potassium hydroxide, may be used.
  • an acid e.g., hydrochloric acid, sulfuric acid, or nitric acid
  • an alkali e.g., an aqueous solution of sodium hydroxide or an aqueous solution of potassium hydroxide
  • the calcium concentration in the treated water is, for example, in the range of 0.1 to 500 mg/L
  • the aluminum concentration is, for example, in the range of 0.25 to 5 mg/L
  • the silica concentration is, for example, in the range of 120 to 400 mg/L.
  • the scale inhibitors used include copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) as structural units, phosphonic acid compounds, and polymers containing tert-butyl groups. From the viewpoint of a large anionic charge, copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as structural units and phosphonic acid compounds are preferred.
  • AMPS 2-acrylamido-2-methylpropanesulfonic acid
  • Copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) as structural units include copolymers of acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid, terpolymers of acrylic acid, 2-acrylamido-2-methylpropanesulfonic acid, and substituted acrylamide, and terpolymers of acrylic acid, 2-acrylamido-2-methylpropanesulfonic acid, and a monomer having a tert-butyl group.
  • AMPS 2-acrylamido-2-methylpropanesulfonic acid
  • the weight average molecular weight of the copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units is not particularly limited, but is, for example, in the range of 2000 to 11000, and preferably in the range of 4000 to 5000. If the weight average molecular weight of this copolymer is less than 2000, the steric hindrance effect in suppressing scale may be insufficient, and if it exceeds 11000, the reverse osmosis membrane may be clogged.
  • the molar ratio of acrylic acid to 2-acrylamido-2-methylpropanesulfonic acid in this copolymer is not particularly limited, but is, for example, in the range of 80:20 to 70:30, and preferably in the range of 78:22 to 72:28. If the molar ratio of acrylic acid to 2-acrylamido-2-methylpropanesulfonic acid in the copolymer is less than 70:30, the ability to chelate cations may be insufficient, and if the amount of 2-acrylamido-2-methylpropanesulfonic acid is less than 80:20, the dispersion force due to charge repulsion of the scale inhibitor polymer itself may be insufficient.
  • Phosphonic acid compounds include those that function primarily as scale dispersants, such as 1-hydroxyethylidene-1,1-diphosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, hydroxyphosphonoacetic acid, nitrilotrimethylenephosphonic acid, ethylenediamine-N,N,N',N'-tetramethylenephosphonic acid, or at least one compound selected from the group consisting of alkali metal salts and alkaline earth metal salts of these phosphonic acids.
  • scale dispersants such as 1-hydroxyethylidene-1,1-diphosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, hydroxyphosphonoacetic acid, nitrilotrimethylenephosphonic acid, ethylenediamine-N,N,N',N'-tetramethylenephosphonic acid, or at least one compound selected from the group consisting of alkali metal salts and alkaline earth metal salts of these
  • One or more types of copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) as constituent units may be used, one or more types of phosphonic acid compounds may be used, or one or more types of copolymers containing acrylic acid and AMPS as constituent units may be used in combination with one or more types of phosphonic acid compounds.
  • AMPS 2-acrylamido-2-methylpropanesulfonic acid
  • a copolymer containing a predetermined amount of acrylic acid and AMPS as constituent units and a predetermined amount of a phosphonic acid compound may be mixed and added to the water to be treated, or a copolymer containing a predetermined amount of acrylic acid and AMPS as constituent units and a predetermined amount of a phosphonic acid compound may be added separately to the water to be treated.
  • the amount of scale inhibitor in the water to be treated may be, for example, in the range of 0.1 to 50 mg/L relative to the amount of water to be treated, and preferably in the range of 1 to 20 mg/L. If the amount of scale inhibitor is less than 0.1 mg/L relative to the amount of water to be treated, the scale inhibition effect may not be obtained, and if it exceeds 50 mg/L, the scale inhibition effect relative to the chemical ratio may be small and running costs may increase.
  • the Langelier Saturation Index (LSI) of the concentrated water is preferably greater than 0, and more preferably 0.16 or greater. If the Langelier Saturation Index of the concentrated water is 0 or less, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the Langelier Saturation Index of the concentrated water, but it is, for example, 3.0.
  • the LSI can be calculated by the following formula (1), and can be calculated, for example, by desk calculation or using calculation software provided by a separation membrane manufacturer or a scale inhibitor manufacturer.
  • LSI pH-pHs+1.5 ⁇ 10-2 ⁇ (T-25)
  • pHs 8.313-log(Ca 2+ )-log(A)+S
  • pH is the pH of water
  • T is the water temperature [°C]
  • (Ca 2+ ) is the milliequivalent concentration of Ca 2+ [meq/L]
  • (A) is the milliequivalent concentration of total alkalinity [meq/L]
  • the calcium concentration in the concentrated water is preferably 0.1 mg/L or more, and more preferably 1 mg/L or more. If the calcium concentration in the concentrated water is less than 0.1 mg/L, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the calcium concentration in the concentrated water, but it is, for example, 500 mg/L.
  • the silica concentration in the concentrated water is preferably 120 mg/L or more, and more preferably 150 mg/L or more. If the silica concentration in the concentrated water is less than 120 mg/L, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the silica concentration in the concentrated water, but it is, for example, 400 mg/L.
  • the aluminum concentration in the concentrated water is preferably 0.25 mg/L or more, and more preferably 5 mg/L or more. If the aluminum concentration in the concentrated water is less than 0.25 mg/L, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the aluminum concentration in the concentrated water, but it is, for example, 10 mg/L.
  • a reverse osmosis membrane treatment means for passing water to be treated, which contains at least one of calcium and aluminum, through a reverse osmosis membrane to obtain a permeate and a concentrated water;
  • a scale inhibitor adding means for adding a scale inhibitor to the water to be treated, The water treatment device, wherein the reverse osmosis membrane is a neutrally charged membrane.
  • the water treatment device according to [1]
  • the water to be treated further contains silica.
  • the water treatment device includes at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.
  • a reverse osmosis membrane treatment step in which water to be treated containing at least one of calcium and aluminum is passed through a reverse osmosis membrane to obtain a permeate and a concentrated water;
  • the scale inhibitor comprises at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.
  • RO flat membrane water flow test An RO flat membrane water passing test was carried out. A predetermined amount of each solute was dissolved in pure water to prepare raw water. The ionic silica concentration was adjusted to a predetermined concentration using sodium metasilicate, the aluminum ion concentration was adjusted to a predetermined concentration using aluminum chloride, the calcium ion concentration was adjusted to a predetermined concentration using calcium chloride, the magnesium ion concentration was adjusted to a predetermined concentration using magnesium chloride, and the bicarbonate ion was adjusted to a predetermined concentration using sodium bicarbonate. The concentration of the soluble substance was a predetermined concentration of 500 to 1000 [mg/L]. The pH of the raw water was adjusted to pH 7.5 using hydrochloric acid or sodium hydroxide. The water was passed through the flat membrane at a room temperature of 25 ⁇ 2°C. The raw water in this flat membrane water passing test was simulated as RO concentrated water when passing through a reverse osmosis membrane element.
  • Flux refers to the permeation flux, and is calculated by the amount of permeate water [g] / density of water [g/mL] / membrane area [m 2 ]. Thereafter, the flux was measured over time, and the ratio [%] of the flux at each time to the initial flux was recorded as the flux retention rate [%].
  • the treated water is separated into permeate water and concentrated water by the reverse osmosis membrane, with a recovery rate of, for example, around 50% to 90%, which translates to a concentration rate of around 2 to 10 times.
  • the recovery rate in a flat membrane water flow test is, for example, around 0.01% to 0.05%, so the quality of the raw water is approximately equal to the quality of the concentrated water. This is because the flat membrane water flow test is a research method used at the laboratory level, and its purpose is to reduce the amount of sample water required to conduct the test.
  • the risk of clogging is evaluated by passing water simulating concentrated water, which has the highest concentration of clogging substances, through the reverse osmosis membrane.
  • the zeta potential of the reverse osmosis membrane was determined using the ELSZ series zeta potential/particle size measurement system manufactured by Otsuka Electronics Co., Ltd.
  • the zeta potential of the reverse osmosis membrane was calculated from the measured electroosmosis plot using the Mori-Okamoto formula and the Smoluchowski formula below.
  • the physical properties of the solvent used were those of pure water at 25°C (refractive index: 1.3328, viscosity: 0.8878, dielectric constant: 78.3).
  • Example 1 and Comparative Example 1 The raw water was adjusted so that the concentration of each solute was the value shown in Table 1.
  • the LSI of the raw water of the water quality in Table 1 was calculated to be 0.17.
  • the pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed.
  • As the scale inhibitor a binary copolymer polymer (weight average molecular weight: 4500) of acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) mixed with 2-phosphonobutane-1,2,4-tricarboxylic acid as a phosphonic acid compound was used.
  • AMPS 2-acrylamido-2-methylpropanesulfonic acid
  • the amount of the scale inhibitor in the treated water was added so that the binary copolymer polymer was 11.5 mg/L and the phosphonic acid compound was 4.3 mg/L relative to the amount of raw water.
  • a neutral charged membrane (BW30XFR) manufactured by Film Tec was used as the reverse osmosis membrane.
  • the zeta potential of BW30XFR was measured to be -7.9 mV.
  • an anion-charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • the zeta potential of ES20 was measured and found to be ⁇ 35 mV.
  • Example 2 Comparative Example 2> The raw water was adjusted so that the concentration of each solute was the value shown in Table 2. The LSI of the raw water of the water quality in Table 2 was calculated to be 0.21. The pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed. The above-mentioned binary copolymer of acrylic acid and AMPS was used as the scale inhibitor. The amount of the scale inhibitor in the treated water was added so that the binary copolymer was 46 mg/L relative to the amount of raw water. In Example 2, a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. The zeta potential of LFC3 was measured to be -1.3 mV. In Comparative Example 2, an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • LFC3 neutral charged membrane
  • ES20 anion charged membrane manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane
  • Example 3 Comparative Example 3> The raw water was adjusted so that the concentration of each solute was the value shown in Table 3. The LSI of the raw water of the water quality in Table 3 was calculated to be 0.49. The pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed.
  • As the scale inhibitor a mixture of the above-mentioned phosphonic acid compound and the binary copolymer of acrylic acid and AMPS was used. The amount of the scale inhibitor in the treated water was the same as that in Example 2.
  • a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • Example 4 Comparative Example 4> The raw water was adjusted so that the concentration of each solute was the value shown in Table 4. The LSI of the raw water of the water quality in Table 4 was calculated to be -0.84. The pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed. The above-mentioned binary copolymer of acrylic acid and AMPS was used as the scale inhibitor. The amount of the scale inhibitor in the water to be treated was added so that the binary copolymer was 13.8 mg/L relative to the amount of raw water. In Example 4, a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. In Comparative Example 4, an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • LFC3 neutral charged membrane
  • ES20 anion charged membrane manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • Figure 4 shows the change in flux retention rate (%) versus operating time (hr). Although the conditions were such that LSI ⁇ 0, a slight decrease in flux was observed. This is thought to be due to scale caused by silica or aluminum, rather than hardness components. Even in this case, Example 4 was able to maintain a higher flux retention rate than Comparative Example 4.
  • Example 5 Comparative Example 5> The raw water was adjusted so that the concentration of each solute was the value shown in Table 5. The LSI of the raw water of the water quality in Table 5 was calculated to be 0.17.
  • the scale inhibitor a mixture of the binary copolymer of acrylic acid and AMPS and the phosphonic acid compound was used. The amount of the scale inhibitor in the treated water was added so that the binary copolymer was 100 mg/L relative to the amount of raw water.
  • a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.
  • the operating pressure of the pump was set to 1.22 MPa for LFC3 and 0.75 MPa for ES20.
  • the permeation rates [g/min] of LFC3 and ES20 were made equal to each other, and an RO flat membrane water flow test was performed.
  • the device and method of the embodiment were able to suppress the progression of blockage of the reverse osmosis membrane caused by scale during reverse osmosis membrane treatment.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

Provided are a water treatment apparatus and a water treatment method, with which it is possible to suppress the progress of clogging of a reverse osmosis membrane caused by scales in a reverse osmosis membrane treatment. A water treatment apparatus (1) comprises: a reverse osmosis membrane treatment device (12) for passing water to be treated through a reverse osmosis membrane so as to obtain permeated water and concentrated water, the water to be treated containing at least one of calcium and aluminum; and a scale inhibitor addition pipe (22) for adding a scale inhibitor to the water to be treated. The reverse osmosis membrane is a neutrally charged membrane.

Description

水処理装置および水処理方法Water treatment device and water treatment method

 本発明は、逆浸透膜を用いる水処理装置および水処理方法に関する。 The present invention relates to a water treatment device and a water treatment method that use a reverse osmosis membrane.

 近年、純水製造や水回収などの水処理において逆浸透膜が用いられる機会が増加している。被処理水中の溶質が逆浸透膜処理によって濃縮され、溶質の溶解度を超え、スケールとして析出して逆浸透膜の膜面を閉塞させるスケーリングは、逆浸透膜を代表するトラブルの1つである。代表的なスケール成分としては、カルシウム、アルミニウム、シリカなどがある。 In recent years, reverse osmosis membranes have been increasingly used in water treatment processes such as pure water production and water recovery. Scaling, which occurs when solutes in the water being treated are concentrated by the reverse osmosis membrane process and exceed the solubility of the solute, precipitates as scale and clogs the membrane surface of the reverse osmosis membrane, is one of the most common problems with reverse osmosis membranes. Typical scale components include calcium, aluminum, and silica.

 スケーリングの対策として、逆浸透膜処理の濃縮水におけるスケール成分の濃度が、原則として、溶質の各々の溶解度を超えないように、また、ランゲリア指数LSI<0となるように、逆浸透膜処理装置の回収率を決定している。ここで、LSI(ランゲリア指数、Langelier Saturation Index)とは、硬度成分を含むスケールリスクの指標として知られており、水のpH、カルシウムイオン濃度、総アルカリ度、および溶解性物質濃度から求められる。この値が大きくなるほど、炭酸カルシウムの析出が生じやすくなり、他にも炭酸カルシウムを核とした、類似した性質を持つスケールの析出や共沈が生じやすくなる。LSIは、後述する式(1)にて算出することができる。 As a countermeasure against scaling, the recovery rate of the reverse osmosis membrane treatment equipment is determined so that the concentration of scale components in the concentrated water from the reverse osmosis membrane treatment does not exceed the solubility of each solute, and the Langelier index (LSI) is less than 0. Here, LSI (Langelier Saturation Index) is known as an index of the risk of scale including hardness components, and is calculated from the pH, calcium ion concentration, total alkalinity, and soluble substance concentration of the water. The larger this value is, the more likely it is that calcium carbonate will precipitate, and the more likely it is that other scales with similar properties, centered around calcium carbonate, will precipitate or co-precipitate. LSI can be calculated using formula (1) described below.

 一般的には、スケール成分の濃度が高いほどLSIの数値が高くなるため、LSI<0で管理することが推奨されている。さらには、その他のスケーリングの対策として、逆浸透膜処理の供給水にスケール抑制剤を添加することが知られている。例えば、特許文献1には、実施例にて、アニオン荷電膜(日東電工製超低圧RO膜「ES20」)を用いる逆浸透膜処理の供給水にスケールを分散させる薬剤(スケール抑制剤)を添加することが記載されている。 Generally, the higher the concentration of scale components, the higher the LSI value, so it is recommended to keep LSI < 0. Furthermore, as another measure against scaling, it is known to add a scale inhibitor to the feed water for reverse osmosis membrane treatment. For example, in the examples of Patent Document 1, it is described that an agent (scale inhibitor) that disperses scale is added to the feed water for reverse osmosis membrane treatment that uses an anion-charged membrane (ultra-low pressure RO membrane "ES20" manufactured by Nitto Denko).

 しかし、LSI<0として回収率を下げることは、逆浸透膜の膜本数の増加やシステムの増大に繋がり、イニシャルコスト、ランニングコストを増加させる。さらに近年は、局所的な水不足や、水循環利用の広まりから、逆浸透膜処理の被処理水中のスケール成分の濃度が上昇しており、スケール抑制剤の添加だけでは、スケールによる膜閉塞の進行を抑制することが難しくなってきている。そのため、スケール抑制剤だけではなく、効果的なスケールの抑制手段が求められる。 However, lowering the recovery rate by setting LSI<0 leads to an increase in the number of reverse osmosis membranes and an increase in the size of the system, which increases initial and running costs. Furthermore, in recent years, the concentration of scale components in the water being treated by reverse osmosis membranes has been increasing due to localized water shortages and the spread of water recycling, making it difficult to suppress the progression of membrane blockage caused by scale by adding scale inhibitors alone. Therefore, there is a demand for effective means of suppressing scale, in addition to scale inhibitors.

特許第6512322号公報Patent No. 6512322

 本発明の目的は、逆浸透膜処理においてスケールによる逆浸透膜の閉塞の進行を抑制することができる水処理装置および水処理方法を提供することにある。 The object of the present invention is to provide a water treatment device and a water treatment method that can suppress the progression of clogging of the reverse osmosis membrane caused by scale during reverse osmosis membrane treatment.

 本発明は、カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理手段と、前記被処理水にスケール抑制剤を添加するためのスケール抑制剤添加手段と、を備え、前記逆浸透膜は中性荷電膜である、水処理装置である。 The present invention is a water treatment device that includes a reverse osmosis membrane treatment means for passing water to be treated that contains at least one of calcium and aluminum through a reverse osmosis membrane to obtain permeate water and concentrated water, and a scale inhibitor addition means for adding a scale inhibitor to the water to be treated, the reverse osmosis membrane being a neutrally charged membrane.

 前記水処理装置において、前記被処理水は、さらにシリカを含むことが好ましい。 In the water treatment device, it is preferable that the water to be treated further contains silica.

 前記水処理装置において、前記スケール抑制剤は、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体、およびホスホン酸化合物のうちの少なくとも1つを含むことが好ましい。 In the water treatment device, the scale inhibitor preferably contains at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.

 前記水処理装置において、前記中性荷電膜は、膜表面のゼータ電位が-10mV以上+10mV以下である中性荷電膜であることが好ましい。 In the water treatment device, it is preferable that the neutrally charged membrane is a neutrally charged membrane with a zeta potential on the membrane surface of -10 mV or more and +10 mV or less.

 前記水処理装置において、前記濃縮水におけるランゲリア指数が、0を超えることが好ましい。 In the water treatment device, it is preferable that the Langelier index of the concentrated water exceeds 0.

 前記水処理装置において、前記濃縮水におけるシリカ濃度が、120mg/L以上であることが好ましい。 In the water treatment device, it is preferable that the silica concentration in the concentrated water is 120 mg/L or more.

 前記水処理装置において、前記濃縮水におけるアルミニウム濃度が、0.25mg/L以上であることが好ましい。 In the water treatment device, it is preferable that the aluminum concentration in the concentrated water is 0.25 mg/L or more.

 前記水処理装置において、前記濃縮水における、ランゲリア指数が、0を超え、シリカ濃度が、120mg/L以上であり、アルミニウム濃度が、0.25mg/L以上であることが好ましい。 In the water treatment device, it is preferable that the concentrated water has a Langelier index greater than 0, a silica concentration of 120 mg/L or more, and an aluminum concentration of 0.25 mg/L or more.

 本発明は、カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理工程と、前記被処理水にスケール抑制剤を添加するスケール抑制剤添加工程と、を含み、前記逆浸透膜は中性荷電膜である、水処理方法である。 The present invention is a water treatment method that includes a reverse osmosis membrane treatment step in which water to be treated that contains at least one of calcium and aluminum is passed through a reverse osmosis membrane to obtain permeate water and concentrated water, and a scale inhibitor addition step in which a scale inhibitor is added to the water to be treated, the reverse osmosis membrane being a neutrally charged membrane.

 前記水処理方法において、前記被処理水は、さらにシリカを含むことが好ましい。 In the water treatment method, it is preferable that the water to be treated further contains silica.

 前記水処理方法において、前記スケール抑制剤は、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体、およびホスホン酸化合物のうちの少なくとも1つを含むことが好ましい。 In the water treatment method, the scale inhibitor preferably contains at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.

 前記水処理方法において、前記中性荷電膜は、膜表面のゼータ電位が-10mV以上+10mV以下である中性荷電膜であることが好ましい。 In the water treatment method, it is preferable that the neutrally charged membrane is a neutrally charged membrane whose membrane surface has a zeta potential of -10 mV or more and +10 mV or less.

 前記水処理方法において、前記濃縮水におけるランゲリア指数が、0を超えることが好ましい。 In the water treatment method, it is preferable that the Langelier index of the concentrated water exceeds 0.

 前記水処理方法において、前記濃縮水におけるシリカ濃度が、120mg/L以上であることが好ましい。 In the water treatment method, it is preferable that the silica concentration in the concentrated water is 120 mg/L or more.

 前記水処理方法において、前記濃縮水におけるアルミニウム濃度が、0.25mg/L以上であることが好ましい。 In the water treatment method, it is preferable that the aluminum concentration in the concentrated water is 0.25 mg/L or more.

 前記水処理方法において、記濃縮水における、ランゲリア指数が、0を超え、シリカ濃度が、120mg/L以上であり、アルミニウム濃度が、0.25mg/L以上であることが好ましい。 In the water treatment method, it is preferable that the concentrated water has a Langelier index greater than 0, a silica concentration of 120 mg/L or more, and an aluminum concentration of 0.25 mg/L or more.

 本発明によって、逆浸透膜処理においてスケールによる逆浸透膜の閉塞の進行を抑制することができる水処理装置および水処理方法を提供することができる。 The present invention provides a water treatment device and a water treatment method that can suppress the progression of blockage of the reverse osmosis membrane caused by scale during reverse osmosis membrane treatment.

本発明の実施形態に係る水処理装置の一例を示す概略構成図である。1 is a schematic diagram illustrating an example of a water treatment device according to an embodiment of the present invention. 実施例1、比較例1におけるFlux保持率(%)の運転時間(hr)に対する推移を示すグラフである。1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 1 and Comparative Example 1. 実施例2、比較例2におけるFlux保持率(%)の運転時間(hr)に対する推移を示すグラフである。1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 2 and Comparative Example 2. 実施例3、比較例3におけるFlux保持率(%)の運転時間(hr)に対する推移を示すグラフである。1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 3 and Comparative Example 3. 実施例4、比較例4におけるFlux保持率(%)の運転時間(hr)に対する推移を示すグラフである。1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 4 and Comparative Example 4. 実施例5、比較例5におけるFlux保持率(%)の運転時間(hr)に対する推移を示すグラフである。1 is a graph showing the change in flux retention (%) versus operation time (hr) in Example 5 and Comparative Example 5.

 本発明の実施の形態について以下説明する。本実施形態は本発明を実施する一例であって、本発明は本実施形態に限定されるものではない。 The following describes an embodiment of the present invention. This embodiment is an example of implementing the present invention, and the present invention is not limited to this embodiment.

 本発明の実施形態に係る水処理装置は、カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理手段と、被処理水にスケール抑制剤を添加するためのスケール抑制剤添加手段と、を備え、逆浸透膜は中性荷電膜である、水処理装置である。 The water treatment device according to an embodiment of the present invention is a water treatment device that includes a reverse osmosis membrane treatment means for passing water to be treated that contains at least one of calcium and aluminum through a reverse osmosis membrane to obtain permeate water and concentrated water, and a scale inhibitor addition means for adding a scale inhibitor to the water to be treated, and the reverse osmosis membrane is a neutrally charged membrane.

 本発明の実施形態に係る水処理装置の一例の概略を図1に示し、その構成について説明する。  An example of a water treatment device according to an embodiment of the present invention is outlined in FIG. 1, and its configuration will be described.

 水処理装置1は、カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理手段として、逆浸透膜処理装置12を備える。逆浸透膜処理装置12において用いられる逆浸透膜は中性荷電膜である。水処理装置1は、カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を貯留する被処理水槽10を備えてもよい。 The water treatment device 1 includes a reverse osmosis membrane treatment device 12 as a reverse osmosis membrane treatment means for passing water to be treated, which contains at least one of calcium and aluminum, through a reverse osmosis membrane to obtain permeate water and concentrated water. The reverse osmosis membrane used in the reverse osmosis membrane treatment device 12 is a neutrally charged membrane. The water treatment device 1 may also include a water tank 10 for storing water to be treated, which contains at least one of calcium and aluminum.

 図1の水処理装置1において、被処理水槽10の被処理水入口には、被処理水配管14が接続されている。被処理水槽10の被処理水出口と逆浸透膜処理装置12の被処理水入口とは、被処理水配管16により接続されている。逆浸透膜処理装置12の透過水出口には、透過水配管18が接続され、濃縮水出口には、濃縮水配管20が接続されている。被処理水槽10の薬剤入口には、スケール抑制剤添加配管22が接続されている。 In the water treatment device 1 of Figure 1, a treated water pipe 14 is connected to the treated water inlet of the treated water tank 10. The treated water outlet of the treated water tank 10 and the treated water inlet of the reverse osmosis membrane treatment device 12 are connected by a treated water pipe 16. A permeated water pipe 18 is connected to the permeated water outlet of the reverse osmosis membrane treatment device 12, and a concentrated water pipe 20 is connected to the concentrated water outlet. A scale inhibitor addition pipe 22 is connected to the chemical inlet of the treated water tank 10.

 図1の水処理装置1において、カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水は、被処理水配管14を通して必要に応じて被処理水槽10に貯留される。ここで、被処理水槽10において、被処理水にスケール抑制剤添加配管22を通してスケール抑制剤が添加される(スケール抑制剤添加工程)。スケール抑制剤が添加された被処理水は、被処理水配管16を通して逆浸透膜処理装置12に送液される。スケール抑制剤は、被処理水配管14または被処理水配管16においてライン添加されてもよい。 In the water treatment device 1 of FIG. 1, the water to be treated, which contains at least one of calcium and aluminum, is stored in the water to be treated tank 10 as necessary through the water to be treated piping 14. Here, in the water to be treated tank 10, a scale inhibitor is added to the water to be treated through the scale inhibitor addition piping 22 (scale inhibitor addition process). The water to be treated to which the scale inhibitor has been added is sent to the reverse osmosis membrane treatment device 12 through the water to be treated piping 16. The scale inhibitor may be added via a line in the water to be treated piping 14 or the water to be treated piping 16.

 逆浸透膜処理装置12において、被処理水が逆浸透膜に通水されて透過水と濃縮水とを得る逆浸透膜処理が行われる(逆浸透膜処理工程)。透過水は、透過水配管18を通して排出され、濃縮水は、濃縮水配管20を通して排出される。 In the reverse osmosis membrane treatment device 12, reverse osmosis membrane treatment is performed in which the water to be treated is passed through a reverse osmosis membrane to obtain permeated water and concentrated water (reverse osmosis membrane treatment process). The permeated water is discharged through the permeated water pipe 18, and the concentrated water is discharged through the concentrated water pipe 20.

 これまで、逆浸透膜処理におけるスケールの析出は、濃縮水の溶質濃度、特に逆浸透膜表面近傍での溶質濃度に起因すると考えられており、逆浸透膜の膜種は影響しないと考えられていた。しかし、本発明者らは、逆浸透膜の膜種がスケーリングの進行に影響を与えることを見出した。 Until now, it has been believed that the deposition of scale during reverse osmosis membrane treatment is due to the solute concentration in the concentrated water, particularly near the surface of the reverse osmosis membrane, and that the type of reverse osmosis membrane has no effect. However, the present inventors have discovered that the type of reverse osmosis membrane affects the progression of scaling.

 本発明者らは、逆浸透膜として中性荷電膜を用いた場合、アニオン荷電膜を用いた場合と比較して、スケールによる逆浸透膜の閉塞が進行しにくくなることを見出した。これは、代表的なスケール成分である、カルシウム、アルミニウムなどのカチオンが、アニオン荷電膜では膜近傍に荷電的に引き寄せられ濃縮されて高濃度になるのに対して、中性荷電膜では、その現象が起こりにくいためと考えられる。シリカはアニオン性であるが、カルシウムやアルミニウムなどのカチオンによって析出が促進されることが知られている。よって、シリカの析出を抑制する目的でも、中性荷電膜を使用する効果はあると考えられる。 The inventors have found that when a neutrally charged membrane is used as the reverse osmosis membrane, clogging of the reverse osmosis membrane by scale is less likely to progress compared to when an anion-charged membrane is used. This is thought to be because cations such as calcium and aluminum, which are typical scale components, are attracted to the vicinity of the membrane by charge and concentrated to a high concentration in an anion-charged membrane, whereas this phenomenon is less likely to occur in a neutrally charged membrane. Although silica is anionic, it is known that precipitation is promoted by cations such as calcium and aluminum. Therefore, it is thought that using a neutrally charged membrane is also effective for the purpose of suppressing silica precipitation.

 中性荷電膜は、主に排水処理分野で使用されている。通常、逆浸透膜の表面はアニオン荷電であるが、コーティングなどの表面処理により中性荷電化することによって、主に有機物などによる膜面汚染を抑制する効果がある。一方で、その表面処理のため、アニオン荷電膜と比較して透過水量は低下し、同じ造水量を得ようとした際にはポンプの操作圧、および消費電力が上昇してしまうデメリットがある。そのため、特別な理由がない場合は、アニオン荷電膜を使用するようにするのが一般的である。例えば、地下水から純水を製造する用途では、スケール抑制剤とともにアニオン荷電膜が使用されている。例えば、地下水から純水を製造する用途で地下水中のスケール成分濃度が高い場合は、中性荷電膜を使用することによって、逆浸透膜が閉塞しにくくなり、長期運転における消費電力を抑制することが可能となる。 Neutral-charged membranes are mainly used in the wastewater treatment field. Normally, the surface of a reverse osmosis membrane is anion-charged, but by neutralizing the charge through surface treatment such as coating, it is possible to suppress membrane surface contamination, mainly caused by organic matter. On the other hand, due to the surface treatment, the amount of permeated water is lower than with an anion-charged membrane, and there is a disadvantage that the operating pressure of the pump and power consumption increase when trying to produce the same amount of water. Therefore, unless there is a special reason, it is common to use an anion-charged membrane. For example, in applications where pure water is produced from groundwater, anion-charged membranes are used together with scale inhibitors. For example, in applications where pure water is produced from groundwater and the concentration of scale components in the groundwater is high, using a neutral-charged membrane makes it less likely for the reverse osmosis membrane to become clogged, making it possible to reduce power consumption during long-term operation.

 逆浸透膜には、中性荷電膜、アニオン荷電膜、およびカチオン荷電膜がある。本明細書では、後述する実施例に記載したゼータ電位の測定方法により求めた、pH7.0におけるゼータ電位が-10mV以上10mV以下の範囲である膜を中性荷電膜、10mVを超える膜をカチオン荷電膜、-10mV未満である膜をアニオン荷電膜と定義する。逆浸透膜を汚染しやすい有機物はアニオン性であることが多く、それらの付着を抑制するために、中性膜のゼータ電位は、-10~0mVの範囲であることが好ましい。 Reverse osmosis membranes include neutrally charged membranes, anionically charged membranes, and cationically charged membranes. In this specification, a membrane with a zeta potential at pH 7.0 determined by the zeta potential measurement method described in the Examples below in the range of -10 mV to 10 mV is defined as a neutrally charged membrane, a membrane with a zeta potential of more than 10 mV is defined as a cationically charged membrane, and a membrane with a zeta potential of less than -10 mV is defined as an anionically charged membrane. Organic substances that tend to contaminate reverse osmosis membranes are often anionic, and in order to suppress their adhesion, it is preferable that the zeta potential of a neutral membrane is in the range of -10 to 0 mV.

 市販の中性荷電膜としては、例えば、BW30XFR(ダウ・ケミカル社製)、LFC3(日東電工株式会社製)、TML20(東レ株式会社製)、OFR625(以上、オルガノ株式会社製)などが挙げられる。 Commercially available neutrally charged membranes include, for example, BW30XFR (Dow Chemical Company), LFC3 (Nitto Denko Corporation), TML20 (Toray Industries, Inc.), and OFR625 (all manufactured by Organo Corporation).

 市販のカチオン荷電膜としては、例えば、ES10C(日東電工株式会社製)などが挙げられる。 An example of a commercially available cation-charged membrane is ES10C (manufactured by Nitto Denko Corporation).

 市販のアニオン荷電膜としては、例えば、ES15、ES20、CPA3、CPA5(以上、日東電工株式会社製)、RE-8040BLN(ウンジン社製)などが挙げられる。 Commercially available anion-charged membranes include, for example, ES15, ES20, CPA3, and CPA5 (all manufactured by Nitto Denko Corporation) and RE-8040BLN (manufactured by Woongjin Co., Ltd.).

 被処理水は、カルシウムおよびアルミニウムのうちの少なくとも1つを含む。被処理水は、さらにシリカ、マグネシウムなどを含んでもよい。カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水としては、カルシウムおよびアルミニウムのうちの少なくとも1つを含む水であればよく、特に制限はないが、例えば、凝集処理水、膜ろ過処理水、工業用水などが挙げられる。 The water to be treated contains at least one of calcium and aluminum. The water to be treated may further contain silica, magnesium, etc. The water to be treated containing at least one of calcium and aluminum may be water containing at least one of calcium and aluminum, and is not particularly limited, but examples include coagulation treated water, membrane filtration treated water, industrial water, etc.

 被処理水のpHは、例えば、4.0~10.0の範囲であり、5.5~9.0の範囲であることが好ましい。被処理水のpHが4.0未満であると、逆浸透膜の阻止率が急激に低下し透過水質が悪化する場合があり、10.0を超えると、逆浸透膜が加水分解により劣化する場合がある。 The pH of the water to be treated is, for example, in the range of 4.0 to 10.0, and preferably in the range of 5.5 to 9.0. If the pH of the water to be treated is less than 4.0, the rejection rate of the reverse osmosis membrane may drop sharply and the quality of the permeated water may deteriorate, and if it exceeds 10.0, the reverse osmosis membrane may deteriorate due to hydrolysis.

 被処理水のpH調整に、例えば塩酸、硫酸、硝酸などの酸や、水酸化ナトリウム水溶液、水酸化カリウム水溶液などのアルカリなどのpH調整剤を用いてもよい。 To adjust the pH of the water to be treated, a pH adjuster such as an acid, e.g., hydrochloric acid, sulfuric acid, or nitric acid, or an alkali, e.g., an aqueous solution of sodium hydroxide or an aqueous solution of potassium hydroxide, may be used.

 被処理水のカルシウムの濃度は、例えば、0.1~500mg/Lの範囲であり、アルミニウムの濃度は、例えば、0.25~5mg/Lの範囲であり、シリカの濃度は、例えば、120~400mg/Lの範囲である。 The calcium concentration in the treated water is, for example, in the range of 0.1 to 500 mg/L, the aluminum concentration is, for example, in the range of 0.25 to 5 mg/L, and the silica concentration is, for example, in the range of 120 to 400 mg/L.

 用いるスケール抑制剤は、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸(AMPS)とを構成単位として含有する共重合体、ホスホン酸化合物、tert-ブチル基を有するポリマーなどが挙げられ、アニオン荷電が大きいなどの点から、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体、ホスホン酸化合物が好ましい。 The scale inhibitors used include copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) as structural units, phosphonic acid compounds, and polymers containing tert-butyl groups. From the viewpoint of a large anionic charge, copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as structural units and phosphonic acid compounds are preferred.

 アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸(AMPS)とを構成単位として含有する共重合体としては、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸との共重合体、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸と置換アクリルアミドの三元共重合体、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とtert-ブチル基を有するモノマーとの三元共重合体などが挙げられる。 Copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) as structural units include copolymers of acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid, terpolymers of acrylic acid, 2-acrylamido-2-methylpropanesulfonic acid, and substituted acrylamide, and terpolymers of acrylic acid, 2-acrylamido-2-methylpropanesulfonic acid, and a monomer having a tert-butyl group.

 アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体の重量平均分子量は、特に制限はないが、例えば、2000~11000の範囲であり、4000~5000の範囲であることが好ましい。この共重体の重量平均分子量が2000未満であると、スケール抑制における立体障害効果が不十分となる場合があり、11000を超えると、逆浸透膜が閉塞する場合がある。この共重体におけるアクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とのモル比は、特に制限はないが、例えば、80:20~70:30の範囲であり、78:22~72:28の範囲であることが好ましい。共重体におけるアクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とのモル比において70:30よりアクリル酸の量が少ないと、カチオンをキレート化する能力が不十分になる場合があり、80:20より2-アクリルアミド-2-メチルプロパンスルホン酸の量が少ないと、スケール抑制剤ポリマー自体の荷電反発による分散力が不十分になる場合がある。 The weight average molecular weight of the copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units is not particularly limited, but is, for example, in the range of 2000 to 11000, and preferably in the range of 4000 to 5000. If the weight average molecular weight of this copolymer is less than 2000, the steric hindrance effect in suppressing scale may be insufficient, and if it exceeds 11000, the reverse osmosis membrane may be clogged. The molar ratio of acrylic acid to 2-acrylamido-2-methylpropanesulfonic acid in this copolymer is not particularly limited, but is, for example, in the range of 80:20 to 70:30, and preferably in the range of 78:22 to 72:28. If the molar ratio of acrylic acid to 2-acrylamido-2-methylpropanesulfonic acid in the copolymer is less than 70:30, the ability to chelate cations may be insufficient, and if the amount of 2-acrylamido-2-methylpropanesulfonic acid is less than 80:20, the dispersion force due to charge repulsion of the scale inhibitor polymer itself may be insufficient.

 ホスホン酸化合物としては、主にスケール分散剤として機能するホスホン酸化合物が挙げられ、例えば、1-ヒドロキシエチリデン-1,1-ジホスホン酸、2-ホスホノブタン-1,2,4-トリカルボン酸、ヒドロキシホスホノ酢酸、ニトリロトリメチレンホスホン酸、エチレンジアミン-N,N,N’,N’-テトラメチレンホスホン酸、またはこれらのホスホン酸のアルカリ金属塩およびアルカリ土類金属塩からなる群から選ばれる少なくとも1種の化合物などが挙げられる。 Phosphonic acid compounds include those that function primarily as scale dispersants, such as 1-hydroxyethylidene-1,1-diphosphonic acid, 2-phosphonobutane-1,2,4-tricarboxylic acid, hydroxyphosphonoacetic acid, nitrilotrimethylenephosphonic acid, ethylenediamine-N,N,N',N'-tetramethylenephosphonic acid, or at least one compound selected from the group consisting of alkali metal salts and alkaline earth metal salts of these phosphonic acids.

 アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸(AMPS)とを構成単位として含有する共重合体を1種または2種以上を使用してもよいし、ホスホン酸化合物を1種または2種以上を使用してもよいし、アクリル酸とAMPSとを構成単位として含有する共重合体を1種または2種以上と、ホスホン酸化合物を1種または2種以上とを併用してもよい。併用する場合、例えば、所定量のアクリル酸とAMPSとを構成単位として含有する共重合体と、所定量のホスホン酸化合物と、を混合して被処理水に添加してもよいし、所定量のアクリル酸とAMPSとを構成単位として含有する共重合体と、所定量のホスホン酸化合物と、を別々に被処理水に添加してもよい。 One or more types of copolymers containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) as constituent units may be used, one or more types of phosphonic acid compounds may be used, or one or more types of copolymers containing acrylic acid and AMPS as constituent units may be used in combination with one or more types of phosphonic acid compounds. When using in combination, for example, a copolymer containing a predetermined amount of acrylic acid and AMPS as constituent units and a predetermined amount of a phosphonic acid compound may be mixed and added to the water to be treated, or a copolymer containing a predetermined amount of acrylic acid and AMPS as constituent units and a predetermined amount of a phosphonic acid compound may be added separately to the water to be treated.

 被処理水中のスケール抑制剤の量は、例えば、被処理水の量に対して0.1~50mg/Lの範囲とすればよく、1~20mg/Lの範囲とすることが好ましい。スケール抑制剤の量が被処理水の量に対して0.1mg/L未満であると、スケール抑制効果が得られない場合があり、50mg/Lを超えると、薬品割合に対するスケール抑制効果が小さくなる場合がある上に、ランニングコストが増大する場合がある。 The amount of scale inhibitor in the water to be treated may be, for example, in the range of 0.1 to 50 mg/L relative to the amount of water to be treated, and preferably in the range of 1 to 20 mg/L. If the amount of scale inhibitor is less than 0.1 mg/L relative to the amount of water to be treated, the scale inhibition effect may not be obtained, and if it exceeds 50 mg/L, the scale inhibition effect relative to the chemical ratio may be small and running costs may increase.

 濃縮水におけるランゲリア指数(LSI:Langelier Saturation Index)は、0を超えることが好ましく、0.16以上であることがより好ましい。濃縮水におけるランゲリア指数が0以下であると、逆浸透膜に中性荷電膜を用いなくてもスケールによる膜閉塞が発生しない場合がある。濃縮水におけるランゲリア指数の上限値には特に制限はないが、例えば、3.0である。 The Langelier Saturation Index (LSI) of the concentrated water is preferably greater than 0, and more preferably 0.16 or greater. If the Langelier Saturation Index of the concentrated water is 0 or less, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the Langelier Saturation Index of the concentrated water, but it is, for example, 3.0.

 LSIは、以下の式(1)にて算出することができ、例えば、机上計算や、分離膜メーカーやスケール抑制剤メーカーの提供する計算ソフトで算出することができる。
  LSI=pH-pHs+1.5×10-2×(T-25)     式(1)
  pHs=8.313-log(Ca2+)-log(A)+S
 ここで、pHは水のpH、Tは水温[℃]、(Ca2+)はCa2+のミリ当量濃度[meq/L]、(A)は総アルカリ度のミリ当量濃度[meq/L]、Sは補正値(S=(2×√μ)/(1+√μ)、μ:2.5×10-5×sd)を指す。sdは溶解性物質濃度[mg/L]を指す。
The LSI can be calculated by the following formula (1), and can be calculated, for example, by desk calculation or using calculation software provided by a separation membrane manufacturer or a scale inhibitor manufacturer.
LSI=pH-pHs+1.5× 10-2 ×(T-25) Formula (1)
pHs=8.313-log(Ca 2+ )-log(A)+S
Here, pH is the pH of water, T is the water temperature [°C], (Ca 2+ ) is the milliequivalent concentration of Ca 2+ [meq/L], (A) is the milliequivalent concentration of total alkalinity [meq/L], S is the correction value (S = (2 × √μ)/(1 + √μ), μ: 2.5 × 10 -5 × sd), and sd is the soluble substance concentration [mg/L].

 濃縮水におけるカルシウムの濃度は、0.1mg/L以上であることが好ましく、1mg/L以上であることがより好ましい。濃縮水におけるカルシウムの濃度が0.1mg/L未満であると、逆浸透膜に中性荷電膜を用いなくてもスケールによる膜閉塞が発生しない場合がある。濃縮水におけるカルシウムの濃度の上限値には特に制限はないが、例えば、500mg/Lである。 The calcium concentration in the concentrated water is preferably 0.1 mg/L or more, and more preferably 1 mg/L or more. If the calcium concentration in the concentrated water is less than 0.1 mg/L, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the calcium concentration in the concentrated water, but it is, for example, 500 mg/L.

 濃縮水におけるシリカの濃度は、120mg/L以上であることが好ましく、150mg/L以上であることがより好ましい。濃縮水におけるシリカの濃度が120mg/L未満であると、逆浸透膜に中性荷電膜を用いなくてもスケールによる膜閉塞が発生しない場合がある。濃縮水におけるシリカの濃度の上限値には特に制限はないが、例えば、400mg/Lである。 The silica concentration in the concentrated water is preferably 120 mg/L or more, and more preferably 150 mg/L or more. If the silica concentration in the concentrated water is less than 120 mg/L, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the silica concentration in the concentrated water, but it is, for example, 400 mg/L.

 濃縮水におけるアルミニウムの濃度は、0.25mg/L以上であることが好ましく、5mg/L以上であることがより好ましい。濃縮水におけるアルミニウムの濃度が0.25mg/L未満であると、逆浸透膜に中性荷電膜を用いなくてもスケールによる膜閉塞が発生しない場合がある。濃縮水におけるアルミニウムの濃度の上限値には特に制限はないが、例えば、10mg/Lである。 The aluminum concentration in the concentrated water is preferably 0.25 mg/L or more, and more preferably 5 mg/L or more. If the aluminum concentration in the concentrated water is less than 0.25 mg/L, membrane blockage due to scale may not occur even if a neutrally charged membrane is not used for the reverse osmosis membrane. There is no particular upper limit for the aluminum concentration in the concentrated water, but it is, for example, 10 mg/L.

 本実施形態に係る水処理方法において、上記スケール抑制剤、pH調整剤の他に、スライムコントロール剤、重金属やリン酸塩やアゾール化合物などの防食剤などの他の剤を用いてもよい。 In the water treatment method according to this embodiment, in addition to the above-mentioned scale inhibitors and pH adjusters, other agents such as slime control agents and anticorrosive agents such as heavy metals, phosphates, and azole compounds may also be used.

 本明細書は、以下の実施形態を含む。
[1]カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理手段と、
 前記被処理水にスケール抑制剤を添加するためのスケール抑制剤添加手段と、を備え、
 前記逆浸透膜は中性荷電膜である、水処理装置。
This specification includes the following embodiments.
[1] A reverse osmosis membrane treatment means for passing water to be treated, which contains at least one of calcium and aluminum, through a reverse osmosis membrane to obtain a permeate and a concentrated water;
A scale inhibitor adding means for adding a scale inhibitor to the water to be treated,
The water treatment device, wherein the reverse osmosis membrane is a neutrally charged membrane.

[2][1]に記載の水処理装置であって、
 前記被処理水は、さらにシリカを含む、水処理装置。
[2] The water treatment device according to [1],
The water to be treated further contains silica.

[3][1]または[2]に記載の水処理装置であって、
 前記スケール抑制剤は、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体、およびホスホン酸化合物のうちの少なくとも1つを含む、水処理装置。
[3] The water treatment device according to [1] or [2],
The scale inhibitor in the water treatment device includes at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.

[4][1]~[3]のいずれか1つに記載の水処理装置であって、
 前記中性荷電膜は、膜表面のゼータ電位が-10mV以上+10mV以下である中性荷電膜である、水処理装置。
[4] The water treatment device according to any one of [1] to [3],
The water treatment device, wherein the neutrally charged membrane has a zeta potential of the membrane surface of -10 mV or more and +10 mV or less.

[5][1]~[4]のいずれか1つに記載の水処理装置であって、
 前記濃縮水におけるランゲリア指数が、0を超える、水処理装置。
[5] The water treatment device according to any one of [1] to [4],
The water treatment device, wherein the concentrated water has a Langelier Index of greater than 0.

[6][1]~[5]のいずれか1つに記載の水処理装置であって、
 前記濃縮水におけるシリカ濃度が、120mg/L以上である、水処理装置。
[6] The water treatment device according to any one of [1] to [5],
The water treatment device, wherein the silica concentration in the concentrated water is 120 mg/L or more.

[7][1]~[6]のいずれか1つに記載の水処理装置であって、
 前記濃縮水におけるアルミニウム濃度が、0.25mg/L以上である、水処理装置。
[7] The water treatment device according to any one of [1] to [6],
The water treatment device, wherein the aluminum concentration in the concentrated water is 0.25 mg/L or more.

[8][1]~[4]のいずれか1つに記載の水処理装置であって、
 前記濃縮水における、ランゲリア指数が、0を超え、シリカ濃度が、120mg/L以上であり、アルミニウム濃度が、0.25mg/L以上である、水処理装置。
[8] The water treatment device according to any one of [1] to [4],
The water treatment device, wherein the concentrated water has a Langelier index exceeding 0, a silica concentration of 120 mg/L or more, and an aluminum concentration of 0.25 mg/L or more.

[9]カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理工程と、
 前記被処理水にスケール抑制剤を添加するスケール抑制剤添加工程と、
 を含み、
 前記逆浸透膜は中性荷電膜である、水処理方法。
[9] A reverse osmosis membrane treatment step in which water to be treated containing at least one of calcium and aluminum is passed through a reverse osmosis membrane to obtain a permeate and a concentrated water;
A scale inhibitor adding step of adding a scale inhibitor to the water to be treated;
Including,
The method for treating water, wherein the reverse osmosis membrane is a neutrally charged membrane.

[10][9]に記載の水処理方法であって、
 前記被処理水は、さらにシリカを含む、水処理方法。
[10] The water treatment method according to [9],
The water treatment method, wherein the water to be treated further contains silica.

[11][9]または[10]に記載の水処理方法であって、
 前記スケール抑制剤は、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体、およびホスホン酸化合物のうちの少なくとも1つを含む、水処理方法。
[11] The water treatment method according to [9] or [10],
The scale inhibitor comprises at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.

[12][9]~[11]のいずれか1つに記載の水処理方法であって、
 前記中性荷電膜は、膜表面のゼータ電位が-10mV以上+10mV以下である中性荷電膜である、水処理方法。
[12] The water treatment method according to any one of [9] to [11],
The water treatment method, wherein the neutrally charged membrane has a zeta potential of the membrane surface of -10 mV or more and +10 mV or less.

[13][9]~[12]のいずれか1つに記載の水処理方法であって、
 前記濃縮水におけるランゲリア指数が、0を超える、水処理方法。
[13] The water treatment method according to any one of [9] to [12],
The method for water treatment, wherein the Langelier Index in the concentrate is greater than 0.

[14][9]~[13]のいずれか1つに記載の水処理方法であって、
 前記濃縮水におけるシリカ濃度が、120mg/L以上である、水処理方法。
[14] The water treatment method according to any one of [9] to [13],
The water treatment method, wherein the silica concentration in the concentrated water is 120 mg/L or more.

[15][9]~[14]のいずれか1つに記載の水処理方法であって、
 前記濃縮水におけるアルミニウム濃度が、0.25mg/L以上である、水処理方法。
[15] The water treatment method according to any one of [9] to [14],
The water treatment method, wherein the aluminum concentration in the concentrated water is 0.25 mg/L or more.

[16][9]~[12]のいずれか1つに記載の水処理方法であって、
 前記濃縮水における、ランゲリア指数が、0を超え、シリカ濃度が、120mg/L以上であり、アルミニウム濃度が、0.25mg/L以上である、水処理方法。
[16] The water treatment method according to any one of [9] to [12],
The water treatment method, wherein the concentrated water has a Langelier index of more than 0, a silica concentration of 120 mg/L or more, and an aluminum concentration of 0.25 mg/L or more.

 以下、実施例および比較例を挙げ、本発明をより具体的に詳細に説明するが、本発明は、以下の実施例に限定されるものではない。 The present invention will be explained in more detail below with examples and comparative examples, but the present invention is not limited to the following examples.

[RO平膜通水試験]
 RO平膜通水試験を実施した。純水に各溶質を所定量溶解し、原水を作製した。イオン状シリカ濃度はメタケイ酸ナトリウムを用いて、アルミニウムイオン濃度は塩化アルミニウムを用いて、カルシウムイオン濃度は塩化カルシウムを用いて、マグネシウムイオン濃度は塩化マグネシウムを用いて、炭酸水素イオンは炭酸水素ナトリウムを用いて、それぞれ所定濃度となるよう調整した。なお、溶解性物質の濃度は、500~1000[mg/L]の所定の濃度である。原水のpHは、塩酸、または水酸化ナトリウムを用いて調整し、pH7.5とした。通水は、25±2℃の室温で行った。本平膜通水試験の原水は、逆浸透膜エレメント通水のときのRO濃縮水を模擬している。
[RO flat membrane water flow test]
An RO flat membrane water passing test was carried out. A predetermined amount of each solute was dissolved in pure water to prepare raw water. The ionic silica concentration was adjusted to a predetermined concentration using sodium metasilicate, the aluminum ion concentration was adjusted to a predetermined concentration using aluminum chloride, the calcium ion concentration was adjusted to a predetermined concentration using calcium chloride, the magnesium ion concentration was adjusted to a predetermined concentration using magnesium chloride, and the bicarbonate ion was adjusted to a predetermined concentration using sodium bicarbonate. The concentration of the soluble substance was a predetermined concentration of 500 to 1000 [mg/L]. The pH of the raw water was adjusted to pH 7.5 using hydrochloric acid or sodium hydroxide. The water was passed through the flat membrane at a room temperature of 25±2°C. The raw water in this flat membrane water passing test was simulated as RO concentrated water when passing through a reverse osmosis membrane element.

 RO平膜通水試験では、原水を被処理水として、ポンプを用いて逆浸透膜に供給し、透過水と濃縮水に分離した。透過水は電子天秤の上にサンプリングし、濃縮水は原水タンクに戻した。透過水が系内から抜けた分は、純水を補給した。ポンプの操作圧力は0.75MPa、または1.22MPaとした。濃縮水量は100mL/minとして、透過水量に対して十分な量を確保した。通水開始後、30分ほど待ち、系内全体がほとんど均一になったことを確認し、その時点でのFluxを初期値とした。Fluxとは、透過流束のことを指し、透過水量[g]/水の密度[g/mL]/膜面積[m]で求められる。以降、経時的にFluxを測定し、各時間におけるFluxの、初期Fluxに対する割合[%]をFlux保持率[%]として記録した。 In the RO flat membrane water flow test, raw water was used as the water to be treated, and was fed to the reverse osmosis membrane using a pump, and separated into permeate and concentrated water. The permeate was sampled on an electronic balance, and the concentrated water was returned to the raw water tank. The amount of permeate that was removed from the system was replenished with pure water. The operating pressure of the pump was 0.75 MPa or 1.22 MPa. The amount of concentrated water was 100 mL/min, ensuring a sufficient amount for the amount of permeate. After starting the water flow, it was waited for about 30 minutes to confirm that the entire system was almost uniform, and the flux at that point was taken as the initial value. Flux refers to the permeation flux, and is calculated by the amount of permeate water [g] / density of water [g/mL] / membrane area [m 2 ]. Thereafter, the flux was measured over time, and the ratio [%] of the flux at each time to the initial flux was recorded as the flux retention rate [%].

 なお、一般的な逆浸透膜のエレメント通水においては、被処理水が逆浸透膜によって透過水と濃縮水に分離されるが、その回収率は例えば50%~90%程度、濃縮倍率に換算すると2倍~10倍程度となる。一方、平膜通水試験の回収率は例えば約0.01%~0.05%程度であり、原水水質≒濃縮水水質となる。これは平膜通水試験が実験室レベルで用いられる検討手法であるためであり、試験実施に必要なサンプル水量を減らすことが目的である。平膜通水試験では、最も閉塞物質の濃度が高くなる濃縮水を模擬した水を逆浸透膜に通水することによって閉塞リスクを評価している。 In addition, when water is passed through a typical reverse osmosis membrane element, the treated water is separated into permeate water and concentrated water by the reverse osmosis membrane, with a recovery rate of, for example, around 50% to 90%, which translates to a concentration rate of around 2 to 10 times. On the other hand, the recovery rate in a flat membrane water flow test is, for example, around 0.01% to 0.05%, so the quality of the raw water is approximately equal to the quality of the concentrated water. This is because the flat membrane water flow test is a research method used at the laboratory level, and its purpose is to reduce the amount of sample water required to conduct the test. In a flat membrane water flow test, the risk of clogging is evaluated by passing water simulating concentrated water, which has the highest concentration of clogging substances, through the reverse osmosis membrane.

[逆浸透膜のゼータ電位の測定]
 各逆浸透膜のゼータ電位は、pH4~6の10mM-NaCl水溶液を測定液として、該測定液に15mm×33mm(厚みは5mm以下)の寸法の逆浸透膜を浸漬して、平板電位泳動法により測定した。
[Measurement of Zeta Potential of Reverse Osmosis Membrane]
The zeta potential of each reverse osmosis membrane was measured by plate electrophoresis using a 10 mM NaCl aqueous solution of pH 4 to 6 as the measurement solution, and a reverse osmosis membrane measuring 15 mm×33 mm (thickness 5 mm or less) was immersed in the measurement solution.

 逆浸透膜のゼータ電位は、大塚電子株式会社製、ゼータ電位・粒径測定システムELSZseriesを用いて、求めた。逆浸透膜のゼータ電位は、測定した電気浸透プロットより、下記森・岡本の式およびSmoluchowskiの式から計算した。 The zeta potential of the reverse osmosis membrane was determined using the ELSZ series zeta potential/particle size measurement system manufactured by Otsuka Electronics Co., Ltd. The zeta potential of the reverse osmosis membrane was calculated from the measured electroosmosis plot using the Mori-Okamoto formula and the Smoluchowski formula below.

(森・岡本の式)
 Uobs(z)=AU(z/b)+ΔU(z/b)+(1-A)U+U
 ここで、
 z:セル中心位置からの距離
 Uobs(z):セル中のz位置における見かけの移動度
 A:1/[(2/3)-(0.420166/K)]
  K=a/b: 2aと2bはセル断面の横と縦の長さ、a>b
 U:粒子の真の移動度
 U:セルの上面、下面における平均移動度
 ΔU:セルの上面、下面における移動度の差
(Mori-Okamoto method)
U obs (z)=AU 0 (z/b) 2 +ΔU 0 (z/b)+(1-A)U 0 +U p
Where:
z: distance from the cell center position U obs (z): apparent mobility at z position in the cell A: 1/[(2/3)-(0.420166/K)]
K = a/b: 2a and 2b are the horizontal and vertical lengths of the cell cross section, a>b
U p : True mobility of the particle U 0 : Average mobility on the upper and lower surfaces of the cell ΔU 0 : Difference in mobility on the upper and lower surfaces of the cell

(Smoluchowskiの式)
 ζ=4πηU/ε
 ここで、
 U:電気移動度
 ε:溶媒の誘電率
 η:溶媒の粘度
(Smoluchowski's formula)
ζ=4πηU/ε
Where:
U: Electric mobility ε: Dielectric constant of the solvent η: Viscosity of the solvent

 溶媒の物性値は25℃における純水の値(屈折率:1.3328、粘度:0.8878、誘電率:78.3)を使用した。 The physical properties of the solvent used were those of pure water at 25°C (refractive index: 1.3328, viscosity: 0.8878, dielectric constant: 78.3).

<実施例1、比較例1>
 各溶質濃度が、表1に示す値となるように原水を調整した。表1の水質の原水のLSIを算出したところ、0.17であった。ポンプの操作圧を0.75MPaとし、RO平膜通水試験を実施した。スケール抑制剤としては、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸(AMPS)との二元共重合体ポリマー(重量平均分子量:4500)に、ホスホン酸化合物として2-ホスホノブタン-1,2,4-トリカルボン酸を混合したものを使用した。被処理水中のスケール抑制剤の量は、原水の量に対して二元共重合体ポリマーが11.5mg/L、ホスホン酸化合物が4.3mg/Lとなるように添加した。実施例1では、逆浸透膜として、Film Tec社製の中性荷電膜(BW30XFR)を使用した。BW30XFRのゼータ電位を測定したところ、-7.9mVであった。比較例1では、逆浸透膜として、日東電工社製のアニオン荷電膜(ES20)を使用した。ES20のゼータ電位を測定したところ、-35mVであった。
<Example 1 and Comparative Example 1>
The raw water was adjusted so that the concentration of each solute was the value shown in Table 1. The LSI of the raw water of the water quality in Table 1 was calculated to be 0.17. The pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed. As the scale inhibitor, a binary copolymer polymer (weight average molecular weight: 4500) of acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid (AMPS) mixed with 2-phosphonobutane-1,2,4-tricarboxylic acid as a phosphonic acid compound was used. The amount of the scale inhibitor in the treated water was added so that the binary copolymer polymer was 11.5 mg/L and the phosphonic acid compound was 4.3 mg/L relative to the amount of raw water. In Example 1, a neutral charged membrane (BW30XFR) manufactured by Film Tec was used as the reverse osmosis membrane. The zeta potential of BW30XFR was measured to be -7.9 mV. In Comparative Example 1, an anion-charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. The zeta potential of ES20 was measured and found to be −35 mV.

Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001

 Flux保持率(%)の運転時間(hr)に対する推移を図1に示す。実施例1では、比較例1と比べて、Flux保持率を高く保つことができた。 The change in flux retention rate (%) versus operating time (hr) is shown in Figure 1. In Example 1, the flux retention rate was able to be maintained at a high level compared to Comparative Example 1.

<実施例2、比較例2>
 各溶質濃度が、表2に示す値となるように原水を調整した。表2の水質の原水のLSIを算出したところ、0.21であった。ポンプの操作圧を0.75MPaとし、RO平膜通水試験を実施した。スケール抑制剤としては、上記アクリル酸とAMPSとの二元共重合体ポリマーを使用した。被処理水中のスケール抑制剤の量は、原水の量に対して二元共重合体ポリマーが46mg/Lとなるように添加した。実施例2では、逆浸透膜として、日東電工社製の中性荷電膜(LFC3)を使用した。LFC3のゼータ電位を測定したところ、-1.3mVであった。比較例2では、逆浸透膜として、日東電工社製のアニオン荷電膜(ES20)を使用した。
<Example 2, Comparative Example 2>
The raw water was adjusted so that the concentration of each solute was the value shown in Table 2. The LSI of the raw water of the water quality in Table 2 was calculated to be 0.21. The pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed. The above-mentioned binary copolymer of acrylic acid and AMPS was used as the scale inhibitor. The amount of the scale inhibitor in the treated water was added so that the binary copolymer was 46 mg/L relative to the amount of raw water. In Example 2, a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. The zeta potential of LFC3 was measured to be -1.3 mV. In Comparative Example 2, an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.

Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002

 Flux保持率(%)の運転時間(hr)に対する推移を図2に示す。実施例2では、比較例2と比べて、Flux保持率を高く保つことができた。 The change in flux retention rate (%) versus operating time (hr) is shown in Figure 2. In Example 2, the flux retention rate was able to be maintained at a high level compared to Comparative Example 2.

<実施例3、比較例3>
 各溶質濃度が、表3に示す値となるように原水を調整した。表3の水質の原水のLSIを算出したところ、0.49であった。ポンプの操作圧を0.75MPaとし、RO平膜通水試験を実施した。スケール抑制剤としては、上記アクリル酸とAMPSとの二元共重合体ポリマーに、上記ホスホン酸化合物を混合したものを使用した。被処理水中のスケール抑制剤の量は、実施例2と同じ量とした。実施例3では、逆浸透膜として、日東電工社製の中性荷電膜(LFC3)を使用した。比較例3では、逆浸透膜として、日東電工社製のアニオン荷電膜(ES20)を使用した。
<Example 3, Comparative Example 3>
The raw water was adjusted so that the concentration of each solute was the value shown in Table 3. The LSI of the raw water of the water quality in Table 3 was calculated to be 0.49. The pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed. As the scale inhibitor, a mixture of the above-mentioned phosphonic acid compound and the binary copolymer of acrylic acid and AMPS was used. The amount of the scale inhibitor in the treated water was the same as that in Example 2. In Example 3, a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. In Comparative Example 3, an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.

Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003

 Flux保持率(%)の運転時間(hr)に対する推移を図3に示す。実施例3では、比較例3と比べて、Flux保持率を高く保つことができた。 The change in flux retention rate (%) versus operating time (hr) is shown in Figure 3. In Example 3, the flux retention rate was able to be maintained at a high level compared to Comparative Example 3.

<実施例4、比較例4>
 各溶質濃度が、表4に示す値となるように原水を調整した。表4の水質の原水のLSIを算出したところ、-0.84であった。ポンプの操作圧を0.75MPaとし、RO平膜通水試験を実施した。スケール抑制剤としては、上記アクリル酸とAMPSとの二元共重合体ポリマーを使用した。被処理水中のスケール抑制剤の量は、原水の量に対して二元共重合体ポリマーが13.8mg/Lとなるように添加した。実施例4では、逆浸透膜として、日東電工社製の中性荷電膜(LFC3)を使用した。比較例4では、逆浸透膜として、日東電工社製のアニオン荷電膜(ES20)を使用した。
<Example 4, Comparative Example 4>
The raw water was adjusted so that the concentration of each solute was the value shown in Table 4. The LSI of the raw water of the water quality in Table 4 was calculated to be -0.84. The pump operating pressure was set to 0.75 MPa, and an RO flat membrane water flow test was performed. The above-mentioned binary copolymer of acrylic acid and AMPS was used as the scale inhibitor. The amount of the scale inhibitor in the water to be treated was added so that the binary copolymer was 13.8 mg/L relative to the amount of raw water. In Example 4, a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. In Comparative Example 4, an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane.

Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004

 Flux保持率(%)の運転時間(hr)に対する推移を図4に示す。LSI<0となる条件であったが、Fluxの低下はわずかに観察された。硬度成分ではなく、シリカやアルミニウムによるスケールと考えられる。この場合にも、実施例4では、比較例4と比べて、Flux保持率を高く保つことができた。 Figure 4 shows the change in flux retention rate (%) versus operating time (hr). Although the conditions were such that LSI < 0, a slight decrease in flux was observed. This is thought to be due to scale caused by silica or aluminum, rather than hardness components. Even in this case, Example 4 was able to maintain a higher flux retention rate than Comparative Example 4.

<実施例5、比較例5>
 各溶質濃度が、表5に示す値となるように原水を調整した。表5の水質の原水のLSIを算出したところ、0.17であった。スケール抑制剤としては、上記アクリル酸とAMPSとの二元共重合体ポリマーに、上記ホスホン酸化合物を混合したものを使用した。被処理水中のスケール抑制剤の量は、原水の量に対して二元共重合体ポリマーが100mg/Lとなるように添加した。実施例5では、逆浸透膜として、日東電工社製の中性荷電膜(LFC3)を使用した。比較例5では、逆浸透膜として、日東電工社製のアニオン荷電膜(ES20)を使用した。ポンプの操作圧を、LFC3に関しては1.22MPaとし、ES20については0.75MPaとした。実施例5、比較例5では、こうすることによってLFC3とES20のそれぞれの透過水量[g/min]を等しくして、RO平膜通水試験を行った。
<Example 5, Comparative Example 5>
The raw water was adjusted so that the concentration of each solute was the value shown in Table 5. The LSI of the raw water of the water quality in Table 5 was calculated to be 0.17. As the scale inhibitor, a mixture of the binary copolymer of acrylic acid and AMPS and the phosphonic acid compound was used. The amount of the scale inhibitor in the treated water was added so that the binary copolymer was 100 mg/L relative to the amount of raw water. In Example 5, a neutral charged membrane (LFC3) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. In Comparative Example 5, an anion charged membrane (ES20) manufactured by Nitto Denko Corporation was used as the reverse osmosis membrane. The operating pressure of the pump was set to 1.22 MPa for LFC3 and 0.75 MPa for ES20. In Example 5 and Comparative Example 5, the permeation rates [g/min] of LFC3 and ES20 were made equal to each other, and an RO flat membrane water flow test was performed.

Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005

 Flux保持率(%)の運転時間(hr)に対する推移を図5に示す。実施例5では、比較例5と比べて、Flux保持率を高く保つことができた。 The change in flux retention rate (%) versus operating time (hr) is shown in Figure 5. In Example 5, the flux retention rate was maintained at a high level compared to Comparative Example 5.

 このように、実施例の装置および方法によって、逆浸透膜処理においてスケールによる逆浸透膜の閉塞の進行を抑制することができた。 In this way, the device and method of the embodiment were able to suppress the progression of blockage of the reverse osmosis membrane caused by scale during reverse osmosis membrane treatment.

 1 水処理装置、10 被処理水槽、12 逆浸透膜処理装置、14,16 被処理水配管、18 透過水配管、20 濃縮水配管、22 スケール抑制剤添加配管。 1 Water treatment device, 10 Treated water tank, 12 Reverse osmosis membrane treatment device, 14, 16 Treated water piping, 18 Permeated water piping, 20 Concentrated water piping, 22 Scale inhibitor addition piping.

Claims (12)

 カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理手段と、
 前記被処理水にスケール抑制剤を添加するためのスケール抑制剤添加手段と、を備え、
 前記逆浸透膜は中性荷電膜であることを特徴とする水処理装置。
a reverse osmosis membrane treatment means for passing water to be treated, which contains at least one of calcium and aluminum, through a reverse osmosis membrane to obtain permeated water and concentrated water;
A scale inhibitor adding means for adding a scale inhibitor to the water to be treated,
2. A water treatment device according to claim 1, wherein the reverse osmosis membrane is a neutrally charged membrane.
 請求項1に記載の水処理装置であって、
 前記被処理水は、さらにシリカを含むことを特徴とする水処理装置。
The water treatment device according to claim 1,
The water treatment device according to claim 1, wherein the water to be treated further contains silica.
 請求項1または2に記載の水処理装置であって、
 前記スケール抑制剤は、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体、およびホスホン酸化合物のうちの少なくとも1つを含むことを特徴とする水処理装置。
The water treatment device according to claim 1 or 2,
The water treatment device is characterized in that the scale inhibitor contains at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.
 請求項1~3のいずれか1項に記載の水処理装置であって、
 前記中性荷電膜は、膜表面のゼータ電位が-10mV以上+10mV以下である中性荷電膜であることを特徴とする水処理装置。
The water treatment device according to any one of claims 1 to 3,
The water treatment device is characterized in that the neutrally charged membrane is a neutrally charged membrane having a zeta potential of the membrane surface of -10 mV or more and +10 mV or less.
 カルシウムおよびアルミニウムのうちの少なくとも1つを含む被処理水を逆浸透膜に通水して透過水と濃縮水とを得る逆浸透膜処理工程と、
 前記被処理水にスケール抑制剤を添加するスケール抑制剤添加工程と、
 を含み、
 前記逆浸透膜は中性荷電膜であることを特徴とする水処理方法。
a reverse osmosis membrane treatment step of passing the water to be treated, which contains at least one of calcium and aluminum, through a reverse osmosis membrane to obtain a permeate and a concentrated water;
A scale inhibitor adding step of adding a scale inhibitor to the water to be treated;
Including,
A water treatment method, wherein the reverse osmosis membrane is a neutrally charged membrane.
 請求項5に記載の水処理方法であって、
 前記被処理水は、さらにシリカを含むことを特徴とする水処理方法。
The water treatment method according to claim 5,
The water treatment method, wherein the water to be treated further contains silica.
 請求項5または6に記載の水処理方法であって、
 前記スケール抑制剤は、アクリル酸と2-アクリルアミド-2-メチルプロパンスルホン酸とを構成単位として含有する共重合体、およびホスホン酸化合物のうちの少なくとも1つを含むことを特徴とする水処理方法。
The water treatment method according to claim 5 or 6,
The water treatment method is characterized in that the scale inhibitor contains at least one of a copolymer containing acrylic acid and 2-acrylamido-2-methylpropanesulfonic acid as constituent units, and a phosphonic acid compound.
 請求項5~7のいずれか1項に記載の水処理方法であって、
 前記中性荷電膜は、膜表面のゼータ電位が-10mV以上+10mV以下である中性荷電膜であることを特徴とする水処理方法。
The water treatment method according to any one of claims 5 to 7,
The water treatment method is characterized in that the neutrally charged membrane is a neutrally charged membrane having a zeta potential of the membrane surface of -10 mV or more and +10 mV or less.
 請求項5~8のいずれか1項に記載の水処理方法であって、
 前記濃縮水におけるランゲリア指数が、0を超えることを特徴とする水処理方法。
The water treatment method according to any one of claims 5 to 8,
A water treatment method, characterized in that the concentrated water has a Langelier index of more than 0.
 請求項5~9のいずれか1項に記載の水処理方法であって、
 前記濃縮水におけるシリカ濃度が、120mg/L以上であることを特徴とする水処理方法。
The water treatment method according to any one of claims 5 to 9,
A water treatment method characterized in that the silica concentration in the concentrated water is 120 mg/L or more.
 請求項5~10のいずれか1項に記載の水処理方法であって、
 前記濃縮水におけるアルミニウム濃度が、0.25mg/L以上であることを特徴とする水処理方法。
The water treatment method according to any one of claims 5 to 10,
A water treatment method characterized in that the aluminum concentration in the concentrated water is 0.25 mg/L or more.
 請求項5~8のいずれか1項に記載の水処理方法であって、
 前記濃縮水における、ランゲリア指数が、0を超え、シリカ濃度が、120mg/L以上であり、アルミニウム濃度が、0.25mg/L以上であることを特徴とする水処理方法。
The water treatment method according to any one of claims 5 to 8,
The water treatment method is characterized in that the concentrated water has a Langelier index of more than 0, a silica concentration of 120 mg/L or more, and an aluminum concentration of 0.25 mg/L or more.
PCT/JP2024/013828 2023-07-13 2024-04-03 Water treatment apparatus and water treatment method Pending WO2025013363A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023115064A JP2025012317A (en) 2023-07-13 2023-07-13 Water treatment device and water treatment method
JP2023-115064 2023-07-13

Publications (1)

Publication Number Publication Date
WO2025013363A1 true WO2025013363A1 (en) 2025-01-16

Family

ID=94215098

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2024/013828 Pending WO2025013363A1 (en) 2023-07-13 2024-04-03 Water treatment apparatus and water treatment method

Country Status (3)

Country Link
JP (1) JP2025012317A (en)
TW (1) TW202508980A (en)
WO (1) WO2025013363A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034686A1 (en) * 1996-03-18 1997-09-25 Nitto Denko Corporation Composite reverse osmosis membrane and method of reverse osmotic treatment of water using the same
JPH1147566A (en) * 1997-08-05 1999-02-23 Nitto Denko Corp Water treatment system
JP2018069120A (en) * 2016-10-25 2018-05-10 オルガノ株式会社 Water treatment method and apparatus using reverse osmosis membrane

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034686A1 (en) * 1996-03-18 1997-09-25 Nitto Denko Corporation Composite reverse osmosis membrane and method of reverse osmotic treatment of water using the same
JPH1147566A (en) * 1997-08-05 1999-02-23 Nitto Denko Corp Water treatment system
JP2018069120A (en) * 2016-10-25 2018-05-10 オルガノ株式会社 Water treatment method and apparatus using reverse osmosis membrane

Also Published As

Publication number Publication date
JP2025012317A (en) 2025-01-24
TW202508980A (en) 2025-03-01

Similar Documents

Publication Publication Date Title
KR101682729B1 (en) Method for Inhibiting Scale Formation and Deposition in Membrane Systems via the Use of an AA-AMPS Copolymer
KR101817548B1 (en) Scale inhibiting agent for reverse-osmosis
TWI723224B (en) Operation management method of reverse osmosis membrane device and reverse osmosis membrane treatment system
CN109562962B (en) Membrane filtration method and membrane filtration system
WO2020203527A1 (en) Scale inhibitor for reverse osmosis membranes and reverse osmosis membrane processing method
CN113466420B (en) Scale inhibitor evaluation method and device
WO2025013363A1 (en) Water treatment apparatus and water treatment method
JP7449107B2 (en) Water treatment method and water treatment equipment
JP6974936B2 (en) Water treatment method using reverse osmosis membrane
JP7759216B2 (en) Water treatment method and water treatment device
JP7744212B2 (en) Water treatment method and silica-based scale inhibitor
TW201938256A (en) Scale control method for reverse osmosis membrane
US20210123899A1 (en) Method for determining scale inhibitor concentration in salt water with a calcium/magnesium ionselective electrode
WO2020045004A1 (en) Antifouling agent for separation membranes and antifouling method
JP2025107772A (en) Water treatment method and water treatment device
WO2024166591A1 (en) Water treatment method and water treatment device
TW202327718A (en) Silica contamination inhibition method and silica contamination inhibitor for reverse osmosis membrane system
JP2022154246A (en) Water treatment method and water treatment device
TW202144298A (en) Antifouling agent for separation membranes and method for preventing fouling
JP2019202246A (en) Water treatment equipment and water treatment method
WO2019176156A1 (en) Water treatment apparatus
JP2020093229A (en) Membrane separation method for silica-containing water and membrane separation system for silica-containing water

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24839261

Country of ref document: EP

Kind code of ref document: A1